Latest Research

Biogen CEO Steps Down, Downsizing Sales of Aduhelm

By Simon Spichak, MSc | May 3rd, 2022

Biogen CEO Michel Vounatsos will resign as the company begins to substantially reduce its infrastructure for producing Aduhelm.  UPDATE: 3 March 2024, 8:37 P.M….